Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.

Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer. Gynecol Oncol. 2011 Sep; 122(3):548-53.

View in: PubMed

subject areas

Apolipoprotein A-I
Biomarkers, Tumor
CA-125 Antigen
Case-Control Studies
Female
Humans
Membrane Proteins
Middle Aged
Neoplasm Staging
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Peptide Fragments
Peptides
Prealbumin
Proteomics
Reproducibility of Results
Sensitivity and Specificity
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

authors with profiles

ROBERT C BAST JR
KAREN H LU